| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 5 and exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | alverine/simeticone (SimAlvia®) |
| Formulation | 60 mg/300 mg capsule |
| Reference number | 3465 |
| Indication | Relief of abdominal pain in irritable bowel syndrome |
| Company | HFA Healthcare Ltd |
| BNF chapter | Gastro-intestinal system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 27/03/2017 |